Mutation analysis of the MSMB gene in familial prostate cancer

British Journal of Cancer

Volumn 102, Issue 2, 2010, Pages 414-418

  Kote Jarai, Z ^a   Leongamornlert, D ^a   Tymrakiewicz, M ^a   Field, H ^b   Guy, M ^a   Al Olama, A A ^c   Morrison, J ^b   O'Brien, L ^a   Wilkinson, R ^a   Hall, A ^a   Sawyer, E ^a   Muir, K ^d   Hamdy, F ^e   Donovan, J ^f   Neal, D ^g,h   Easton, D ^c   Eeles, R ^a,i  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

ⁱ INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Gene expression; In silico; MSMB; Prostate cancer; SNP

Indexed keywords

5' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA SEQUENCE; FAMILIAL CANCER; FAMILY HISTORY; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MSMB GENE; MUTATIONAL ANALYSIS; ONCOGENE; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; DNA MUTATIONAL ANALYSIS; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; PROSTATIC SECRETORY PROTEINS;

EID: 75549085710     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605485     Document Type: Article

References (22)

1. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265
2. Bjartell A (2007) PSA and prostate cancer screening: the challenge of the new millennium. Eur Urol 52: 1284-1286
3. Buckland PR, Hoogendoorn B, Coleman SL, Guy CA, Smith SK, O'Donovan MC (2005) Strong bias in the location of functional promoter polymorphisms. Hum Mutat 26: 214-223
4. Cancer Research UK, Statistical Information Team (2008) CancerStats Prostate 2008 [internet]. Cancer Research UK: London http:// publications.cancerresearchuk.org/WebRoot/crukstoredb/CRUK-PDFs/ CSPRO08.pdf
5. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC (1992) Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 89: 3367-3371
6. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T (2005) Matlnspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21: 2933-2942
7. Chang BL, Cramer SD, Wiklund F, Isaacs SD, Stevens VL, Sun J, Smith S, Pruett K, Romero LM, Wiley KE, Kim ST, Zhu Y, Zhang Z, Hsu FC, Turner AR, Adolfsson J, Liu W, Kim JW, Duggan D, Carpten J, Zheng SL, Rodriguez C, Isaacs WB, Gronberg H, Xu J (2009) Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk. Hum Mol Genet 18: 1368-1375
8. Donovan J, Hamdy F, Neal D, Peters T, Oliver S, Brindle L, Jewell D, Powell P, Gillatt D, Dedman D, Mills N, Smith M, Noble S, Lane A (2003) Prostate Testing for Cancer and Treatment (ProtecT) feasibility study. Health Technol Assess 7: 1-88
9. Edwards SM, Eeles RA (2004) Unravelling the genetics of prostate cancer. Am J Med Genet C Semin Med Genet 129C: 65-73
10. Eeles RA (1999) Genetic predisposition to prostate cancer. Prostate Cancer Prostatic Dis 2: 9-15
11. Eeles RA, Kote-Jarai Z, Giles GG, Al Olama AA, Guy M, Jugurnauth SK, Mulholland S, Leongamornlert DA, Edwards SM, Morrison J, Field HI, Southey MC, Severi G, Donovan JL, Hamdy FC, Dearnaley DP, Muir KR, Smith C, Bagnato M, rdern-Jones AT, Hall AL, O'Brien LT, Gehr-Swain BN, Wilkinson RA, Cox A, Lewis S, Brown PM, Jhavar SG, Tymrakiewicz M, Lophatananon A, Bryant SL, Horwich A, Huddart RA, Khoo VS, Parker CC, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Fisher C, Jamieson C, Cooper CS, English DR, Hopper JL, Neal DE, Easton DF (2008) Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 40: 316-321
12. Garde SV, Basrur VS, Li L, Finkelman MA, Krishan A, Wellham L, Ben-Josef E, Haddad M, Taylor JD, Porter AT, Tang DG (1999) Prostate secretory protein (PSP94) suppresses the growth of androgen-independent prostate cancer cell line (PC3) and xenografts by inducing apoptosis. Prostate 38: 118-125
13. Goldgar DE, Easton DF, Cannonalbright LA, Skolnick MH (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86: 1600-1608
14. Gronberg H (2003) Prostate cancer epidemiology. Lancet 361: 859-864
15. Hemminki K, Czene K (2002) Age specific and attributable risks of familial prostate carcinoma from the family-cancer database. Cancer 95: 1346-1353
16. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343: 78-85
17. Lou H, Yeager M, Li H, Bosquet JG, Hayes RB, Orr N, Yu K, Hutchinson A, Jacobs KB, Kraft P, Wacholder S, Chatterjee N, Feigelson HS, Thun MJ, Diver WR, Albanes D, Virtamo J, Weinstein S, Ma J, Gaziano JM, Stampfer M, Schumacher FR, Giovannucci E, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, Crawford ED, Anderson SK, Tucker M, Hoover RN, Fraumeni Jr JF, Thomas G, Hunter DJ, Dean M, Chanock SJ (2009) Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. Proc Natl Acad Sci USA 106: 7933-7938
18. Ochiai Y, Inazawa J, Ueyama H, Ohkubo I (1995) Human gene for beta-microseminoprotein: its promoter structure and chromosomal localization. J Biochem 117: 346-352
19. Reeves JR, Dulude H, Panchal C, Daigneault L, Ramnani DM (2006) Prognostic value of prostate secretory protein of 94 amino acids and its binding protein after radical prostatectomy. Clin Cancer Res 12: 6018-6022
20. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70: 425-434
21. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, Yu K, Chatterjee N, Welch R, Hutchinson A, Crenshaw A, Cancel-Tassin G, Staats BJ, Wang Z, Gonzalez-Bosquet J, Fang J, Deng X, Berndt SI, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cussenot O, Valeri A, Andriole GL, Crawford ED, Tucker M, Gerhard DS, Fraumeni JF, Hoover R, Hayes RB, Hunter DJ, Chanock SJ (2008) Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 40: 310-315
22. Yeager M, Deng Z, Boland J, Matthews C, Bacior J, Lonsberry V, Hutchinson A, Burdett L, Qi L, Jacobs K, Gonzalez-Bosquet J, Berndt S, Hayes R, Hoover R, Thomas G, Hunter D, Dean M, Chanock S (2009) Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer. Hum Genet 2009 Jul 31. E-pub ahead of print. doi: 10.1007/s00439-009-0723-9